SBIR/STTR Research Award

Highly-Multiplexed Capillary Electrophoresis

Award identifier 10d67cd82d8660595bce53400a97e7187770ab9b61a6a8642d37bc1101ee7053Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,420

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CombiSep, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The explosive growth in biological, pharmaceutical, and human health screening technologies has challenged the analytical sciences to create methodologies for high-sample throughput. Of the many possible methodologies, capillary electrophoresis (CE) has an unrecognized potential to serve as a platform for a highly multiplexed analysis system that allows for extremely high sample throughput. However, CE traditionally suffers from unacceptably high sample-to-sample and capillary-to-capillary variations in elution profiles and injection volumes. This variability is one of the main impediments to the use of CE in routine analysis. Furthermore, today's multiplexed CE systems are based only on fluorescence read-out concepts, which are ineffective in detecting -90 percent of the likely target compounds. This project describes the design fabrication, and implementation of a 96-capillary array CE system that 1) employs an absorbance-based read-out methodology and 2) utilizes the near-continuous measurement, collection, and application of the current flow at each individual capillary. The former significantly expands the scope of the system. The latter uses the collected current for self-normalization of the electropherogram through application of the migration index, which can yield precisions that compare favorably with that of high performance liquid chromatography. Success in Phase I will lead to a Phase II program focused on optimizing the system and methods to test biological fluids to perform disease diagnosis and/or prognosis as well as combinatorial drug synthesis and activity screening. Phase II would accumulate in actual field tests being performed and compared to traditional, accepted methods. PROPOSED COMMERCIAL APPLICATION: The ultimate goal of the project for commercial applications is the creation of a packaged system that has proven capabilities for solving problems in the health-related applications (e.g., cancer gene detection, multation analysis, forensic genotyping and drug efficacy) and other areas demanding reliable, high throughput analysis.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.